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Objective To set investment priorities in global mental health research and to propose a more rational use of funds in this under-
resourced and under-investigated area.
Methods Members of the Lancet Mental Health Group systematically listed and scored research investment options on four broad 
classes of disorders: schizophrenia and other major psychotic disorders, major depressive disorder and other common mental 
disorders, alcohol abuse and other substance abuse disorders, and the broad class of child and adolescent mental disorders. Using 
the priority-setting approach of the Child Health and Nutrition Research Initiative, the group listed various research questions and 
evaluated them using the criteria of answerability, effectiveness, deliverability, equity and potential impact on persisting burden of 
mental health disorders. Scores were then weighted according to the system of values expressed by a larger group of stakeholders.
Findings The research questions that scored highest were related to health policy and systems research, where and how to deliver 
existing cost-effective interventions in a low-resource context, and epidemiological research on the broad categories of child and 
adolescent mental disorders or those pertaining to alcohol and drug abuse questions. The questions that scored lowest related to the 
development of new interventions and new drugs or pharmacological agents, vaccines or other technologies.
Conclusion In the context of global mental health and with a time frame of the next 10 years, it would be best to fill critical knowledge 
gaps by investing in research into health policy and systems, epidemiology and improved delivery of cost-effective interventions.
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Introduction
About 14% of the global burden of disease is attributable to 
mental disorders.1 Even in sub-Saharan Africa, where com-
municable diseases are common, mental disorders account for 
nearly 10% of the total burden of disease.2 Mental disorders 
are linked to many other health conditions1 and are among 
the most costly medical disorders to treat.3
Certain treatment and preventive strategies for mental 
disorders are known to be effective (even in low- and middle 
income-countries), particularly those for depressive and anxi-
ety disorders and schizophrenia.4,5 However, health systems 
around the world face a scarcity of financial resources and 
qualified staff – a situation that is often compounded in low- 
and middle-income countries by lack of commitment from 
public health policy makers and inefficient use of resources.6 
As a result, measures known to be effective for dealing with 
mental disorders are often not implemented.
The Global Forum for Health Research has long high-
lighted the major imbalance between the magnitude of mental 
health problems (especially in low- and middle-income coun-
tries) and the resources devoted to addressing them. This is the 
so-called “10/90 gap”; that is, only 10% of global spending on 
health research is directed towards the problems that primarily 
affect the poorest 90% of the world’s population.7 This gap 
stunts the development of evidence-based health policies and 
practice in low- and middle-income countries and limits prog-
ress in medicine and public health.8,9 The impact of the gap 
is particularly evident in the field of mental health, in which 
the evidence base depends mainly on European and North 
American cultural norms.10 Recent studies indicate that up 
to 94% of the published literature in high-impact psychiatric 
journals is from North America, Europe and Australia/New 
Zealand,11 with sometimes as little as 3% originating from 
low- and middle-income countries.11–13
One strategy to redress this imbalance is to invest abun-
dantly in mental health research in low- and middle-income 
countries. The many possibilities for mental health research 
in such countries are beyond the capability of any one gov-
ernment or agency to fund; therefore, guidelines are needed 
to help define priorities for mental health research invest-
ments. Since 1990, several initiatives have been designed to 
set such priorities.14–18 They include the “combined approach 
matrix” priority-setting tool for health research, which was 
applied to schizophrenia;17 a 2001 report from the United 
States National Institute of Mental Health, which outlined 
three priority areas of research in child and adolescent mental 
health;19 and Rosenheck’s seven principles for resource alloca-
tion in the mental health field.14–20
These attempts to set investment priorities have some 
limitations: a focus on the generation of new technologies, 
knowledge and processes, rather than on the implementation 
of already proven interventions;18 insufficient transparency 
around the processes and criteria used to derive the suggested 
investment priorities;19,20 and lack of a clear algorithm and 
method for linking suggested priorities with future invest-
ment decisions.17 The objective of this paper is to address 
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investment priorities in mental health 
research at the global level and to 
propose a more rational use of scarce 
funds in this area by using a systematic 
method for setting priorities in health 
research investments recently developed 
by the Child Health Research Nutrition 
Initiative (CHNRI).18,21 The method 
can be applied in different contexts and 
for different purposes. It has been used 
to set priorities for zinc-related health 
research22 and child health priorities at 
the national level in South Africa.23 It 
is also currently being implemented by 
WHO to set global research priorities 
for eight leading causes of child deaths, 
and by the International Committee on 
Child Development to address research 
priorities to improve child development 
(Rudan I, personal communication).
Methods
Expert group and context
Fig. 1 summarizes the steps involved in 
applying the CHNRI method. The ra-
tionale, conceptual framework and ap-
plication guidelines for the method have 
been described in detail elsewhere.18,21–25 
In applying the CHNRI method in this 
study, the first step was to ask a group 
of leading experts in mental health 
(n = 39) – the Lancet Mental Health 
Group – to form a technical working 
group (Step 1, Fig. 1). The group com-
prised mainly psychiatrists (74%) but 
also included psychologists, epidemi-
ologists, an economist, a primary care 
physician and an anthropologist. It was 
largely composed of males (77%), and 
46% of the members were from low- or 
middle-income countries.
List of research options
Members of the technical working 
group were then asked to generate a 
list of research questions by research 
domain (Step 2, Fig. 1). They proposed 
a total of 290 questions (not all group 
members provided questions for all 
disorders). Many of the questions were 
either identical or sufficiently similar 
to allow them to be combined, and 
three of the authors (MT, VP and 
SS) synthesized them into a final list 
of 55 questions. Research investment 
options were then scored according 
to the five criteria recommended by 
the CHNRI to discriminate between 
suggested research investment options 
Fig. 1. Process for setting research priorities
1. Gather technical experts and define the context
Gather a group of technical experts (Lancet Mental Health Group).a
Define the context in terms of scale (global), time period (10 years), target population
(all people with one of four mental disorders) and disease burden being targeted
(schizophrenia and other major psychotic disorders, major depressive disorder
and other common mental disorders, alcohol abuse and other substance abuse disorder,
and child and adolescent mental disorders).
2. Create a systematic list of research options, by research domain
Use the following domains of research to list research options:
- epidemiological research or research to inform priority setting
- research to improve efficiency of health systems already in place,
focusing on health policy and systems
- research to improve affordability and deliverability of existing interventions
- research to develop new health interventions.
3. Score listed research options by five criteria
Through the technical experts, score the listed research options against the following criteria,
answering three questions against each criterion (Box 1):
- likelihood of answerability in an ethical way
- likelihood of efficacy and effectiveness
- likelihood of deliverability and affordability
- maximum potential for disease burden reduction
- likely impact of equity in population.
4. Address stakeholders’ values
Through the larger reference group, define weights for the five scores. Compute final “research
priority score” (0–100%) as the weighted mean of the intermediate scores.
5. Undertake programme budgeting, marginal analysis and advocacy
For each research option, combine its “value” in terms of the five criteria with its proposed 
cost (in US$); undertake programme budgeting and marginal analysis to derive optimal mix 
of options to be funded.
Through the technical working group, advocate to make the resulting priorities and rationales
accessible to the public, implement mechanisms for decision review, advocate for the implementation
of identified priorities, and evaluate and improve the process based on feedback.
a  Text in parentheses indicates the selections made in this study.
(Step 3, Fig. 1).18,25 Scoring, which 
was voluntary and took place over a 
relatively short period, was eventually 
performed by 24 members (61%) of the 
working group (other eligible members 
were unable to complete scoring due 
to time constraints). The experts who 
completed scoring had a similar profile 
(71% psychiatrists, 83% of them male 
and 38% from low- and middle-income 
countries) to that of the original larger 
group.
The experts answered three ques-
tions related to each criterion (Box 1), 
in line with the conceptual CHNRI 
framework suggested by Rudan et al.25 
In this way, the proposed research 
investment options received five “inter-
mediate scores” (one for each criterion), 
ranging from 0% to 100%. These 
values represented a robust measure of 
the collective view of the experts that 
the option would satisfy the chosen 
criterion.
Reference group
To ensure involvement of the wider 
society in directing research investment 
priorities, we collected opinions from a 
larger reference group, comprising 43 
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Box 1. Questions used by technical experts to assign intermediate scores to competing research questionsa
Criterion 1: likelihood that research would lead to new knowledge (enabling development or planning of an intervention) in an ethical way
1.  Would you say the research question is well framed and end-points are well defined?
2.  Based on the level of existing research capacity in proposed research and the size of the gap from current level of knowledge to the proposed end-
points, would you say that a study can be designed to answer the research question and to reach the proposed end-points of the research?
3.  Do you think that a study needed to answer the proposed research question would obtain ethical approval without major concerns?
Criterion 2: assessment of likelihood that the intervention resulting from proposed research would be effective
1.  Based on the best existing evidence and knowledge, would the intervention that would be developed or improved through the proposed research 
be efficacious?
2.  Based on the best existing evidence and knowledge, would the intervention that would be developed or improved through proposed research be 
effective?
3.  If the answer to either of the previous two questions is positive, would you say that the evidence on which these opinions are based is of high 
quality?
Criterion 3: assessment of deliverability, affordability and sustainability of the intervention resulting from proposed research
1.  Taking into account the level of difficulty with intervention delivery from the perspective of the intervention itself (e.g. design, standardizability, 
safety), the infrastructure required (e.g. human resources, health facilities, communication and transport infrastructure) and users of the 
intervention (e.g. need for change of attitudes or beliefs, supervision, existing demand), would you say that the end-points of the research would 
be deliverable within the context of interest?
2.  Taking into account the resources available to implement the intervention, would you say that the end-points of the research would be affordable 
within the context of interest?
3.  Taking into account government capacity and partnership requirements (e.g. adequacy of government regulation, monitoring and enforcement; 
governmental intersectoral coordination, partnership with civil society and external donor agencies; favourable political climate to achieve high 
coverage), would you say that the end-points of the research would be sustainable within the context of interest?
Criterion 4: assessment of maximum potential of disease burden reduction
As this dimension is considered “independent” of the others, to score competing options fairly, their maximum potential to reduce disease burden 
should be assessed as their potential impact fraction under an ideal scenario; that is, when the exposure to targeted disease risk is decreased to 0% 
or coverage of proposed intervention is increased to 100% (regardless of how realistic that scenario is at the moment – that aspect will be captured 
by other dimensions of the priority setting process, such as deliverability, affordability and sustainability).
For potential interventions:
Maximum potential to reduce disease burden should be computed as “potential impact fraction” for each proposed research avenue, using the equation:
PIF = [S ( i = 1 to n ) P i (RRi − 1)] / [S ( i = 1 to n ) P i (RRi − 1) + 1]
where PIF is the potential impact fraction, i.e. the potential to reduce disease burden through reducing risk exposure in the population from the present 
level to 0% or increasing coverage by an existing or new intervention from the present level to 100%; RR is the relative risk, given the exposure level 
(< 1.0 for interventions, > 1.0 for risks), P is the population level of distribution of exposure, and n is the maximum exposure level.
For existing interventions:
Maximum potential to reduce disease burden should be assessed from the results of conducted intervention trials; if no such trials have been undertaken, 
then it should be assessed as for non-existing interventions, above.
The following questions should then be answered:
1.  Taking into account the results of conducted intervention trials (i.e. existing interventions) or, for the new interventions, the proportion of avertable 
burden under an ideal scenario (i.e. potential interventions), would you say that the successful reaching of research end-points would have a capacity 
to remove 5% of disease burden or more?
2.  To remove 10% of disease burden or more?
3.  To remove 15% of disease burden or more?
Criterion 5: assessment of the impact of proposed health research on equity
1.  Would you say that the present distribution of the disease burden affects mainly the underprivileged in the population?
2.  Would you say that either mainly the underprivileged or all segments of the society equally would be the most likely to benefit from the results of 
the proposed research after its implementation?
3.  Would you say that the proposed research has the overall potential to improve equity in disease burden distribution in the long term (e.g. 10 
years)?
a  Possible answers: yes = 1; no = 0; informed but undecided answer: 0.5; not sufficiently informed: blank.
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stakeholders’ representatives, including 
those from low- and middle-income 
countries. The process of involving 
stakeholders in the CHNRI process has 
been detailed elsewhere.24 The reference 
group comprised nine psychiatrists, 
four psychologists, two social workers, 
three government employees, six non-
governmental organization representa-
tives, six researchers, six users of mental 
health services and seven members of 
the public. We contacted members of 
the group by e-mail and asked them 
to express their opinions through an 
electronic questionnaire that described 
the elements of the process. We asked 
them to rank the five criteria used for 
setting priorities. The criterion for ef-
fectiveness received the highest rank 
(2.47), followed by maximum potential 
for disease burden reduction (2.56), 
deliverability (3.00), predicted effect on 
equity (3.28) and answerability (3.70). 
The next step was to define weights for 
the five scores for each option (Step 4, 
Fig. 1). These observed average ranks 
were then used to compute weights 
by dividing the expected average rank 
in the hypothetical situation of all five 
criteria being equally important (which 
should be 3.00) by the observed average 
rank. These weights were subsequently 
applied to compute intermediate scores. 
Thus, for each scored research invest-
ment option, the intermediate score for 
effectiveness was increased by 21% (i.e. 
3.00/2.47 = 121%) and for maximum 
potential for disease burden reduction, 
by 17%; the score for deliverability 
did not change; and the intermediate 
scores for equity were decreased by 9% 
and for answerability, by 19%. The 
weighted mean of the five intermediate 
scores represented the overall “research 
priority score”, which also ranged from 
0 to 100%.
Computation and assessment
It was not appropriate to use Kappa 
statistics to assess greatest agreement and 
greatest controversy because the data sets 
produced allowed for missing responses, 
“undecided” responses and different 
number of experts scoring different cri-
teria.26 Instead, for each research invest-
ment option, we reported the average 
proportion of scorers that agreed on the 
15 questions asked. This average expert 
agreement (AEA) was computed for each 
scored research investment option as:
where q is a question that experts are 
being asked in order to rank compet-
ing research investment options from 
1 to 15.
For each evaluated research invest-
ment option, the AEA shows the pro-
portion of scorers who gave the same 
most frequent answer to an average 
question (e.g. when the average expert 
agreement is about 60%, this means 
that for an average question related to 
a specific research investment option, 
three out of five scorers gave the most 
frequent answer).
Results
Table 1 and Table 2 show the final 
results (10 highest and 10 lowest priori-
ties) of the scoring process used by the 
technical experts, broken down by type 
of disorder. Appendix A (available at: 
http://academic.sun.ac.za/psychology/
english/TomlinsonM.htm) shows the 
final scores of all proposed research 
options. The five that scored highest 
all addressed either health policy and 
systems research options, epidemio-
logical research or research to inform 
priority setting. The only exception in 
the 10 highest-scoring research prior-
ity options was the one ranked ninth, 
which proposed the development of a 
new intervention. All of the five high-
est-scoring research options addressed 
either alcohol and drug abuse or child 
and adolescent mental disorders.
Of the 10 lowest-scoring research 
options, seven proposed developing 
new interventions and technologies 
(Table 2). Several of the options also tar-
geted the development of new interven-
tions and new drugs or pharmacological 
agents, vaccines or other technologies. 
Of the top 10 options, the only one 
that addressed pharmacological agents 
(Evaluate the effectiveness of dispensation 
of anti-psychotic medication by general 
community health workers in order to 
reduce relapse and admission rates) was 
actually concerned with health systems 
and epidemiological research.
When the scores were broken down 
by type of disorder, a similar pattern 
emerged, with health systems and epi-
demiological research predominating in 
the highest-scoring research options for 
each disorder. New interventions that 
scored highly were those predominantly 
focused on community, social, behav-
ioural and prevention strategies.
The priorities for the competing 
investment options varied widely – 
research priority scores ranged from 
42.2% to 85.9%. Scores for answer-
ability for the 55 research options were 
relatively high (the 47 highest priority 
options all scored above 80%). How-
ever, other criteria helped to lower the 
overall scores. For example, while the 
research option “to develop new, more 
efficacious antipsychotic drugs” scored 
81.7% on answerability, it scored 
poorly on deliverability (31.7%). This 
illustrates the fundamental problem 
of health system delivery that is char-
acteristic of much of the developing 
world. The criterion of reducing the 
burden of disease contributed to low 
overall scores. Apparently the techni-
cal working group felt that, although 
such a question may be answerable, it 
is unlikely to have a strong impact in 
reducing disease.
For the 10 highest priority research 
investment options, the average expert 
agreement parameter was 73.4–78.6%. 
In other words, about three out of four 
scorers gave the same answer to an aver-
age question related to those options. 
This level of agreement is much higher 
than expected from random assignment 
of scores 0 or 1 (less than 50% because 
an “undecided” answer would also be 
allowed). This shows that the experts 
agreed on the priorities overall but not 
on the research investment options at the 
bottom of the ranking list, for which the 
average expert agreement parameter was 
generally 50–60%.
Discussion
To significantly reduce the burden of 
disease caused by the four priority cat-
egories of mental disorders in low- and 
middle-income countries within the 
next 10 years, research funding should 
focus on three areas: health policy and 
systems research; where and how to 
deliver existing cost-effective interven-
tions in a low-resource context; and 
epidemiological research on the broad 
categories of child and adolescent 
mental disorders or those pertaining to 
alcohol and drug abuse. Epidemiologi-
cal research is important because of the 
lack of policy-relevant information in 
the developing world.27
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Table 1. Ten mental health research questions given highest priority by members of the Lancet Mental Health Group, 2008a
Rank Research question Percentage
Disorder Answer-
able?
Effec-
tive?
Deliver-
able?
Maximum 
impact?
Equi-
table?
Weighted 
score
Agree-
ment
1 What HPSR is needed to determine 
the most effective intersectoral (social, 
economic and population-based) 
strategies for reducing consumption 
in high-risk groups (particularly men), 
thus reducing the burden of alcohol 
abuse?
A/DA 90.8 88.8 85.8 81.0 73.3 85.9 76.0
2 What training, support and supervision 
will enable existing maternal and 
child health workers to recognize, and 
provide basic treatment for, common 
maternal, child and adolescent mental 
disorders?
C/AMD 97.2 80.8 89.8 59.8 87.0 83.3 78.5
3 What are the effectiveness and 
cost effectiveness of school-based 
interventions, including for children 
with special needs?
C/AMD 95.2 76.5 91.2 59.2 87.3 82.0 78.6
4 What HSPR is needed to estimate the 
effects of integrating management of 
child and adolescent mental disorders 
with that of other child and adolescent 
physical diseases, including poor 
nutrition?
C/AMD 94.4 75.5 84.3 66.3 84.3 81.4 73.8
5 How effective are early detection and 
simple, brief treatment methods that 
are culturally appropriate, implemented 
by non-specialist health workers in the 
course of routine primary care, and can 
be scaled up?
A/DA 93.3 78.4 88.3 59.6 83.3 81.1 78.5
6 What is the cost effectiveness of trials 
of interventions for CMD in primary and 
secondary care?
CMD 95.5 87.7 79.4 60.0 74.2 80.3 73.4
7 What HSPR is needed to develop 
effective and cost-effective methods 
for delivering family interventions in 
low-resource settings to decrease 
relapses?
S/PSYCH 96.8 83.9 79.4 61.7 74.2 80.0 77.9
8 What HSPR is needed to develop 
feasible, effective and cost-effective 
ways of integrating parenting 
interventions and social skills in early 
childhood care?
C/AMD 81.5 81.5 79.6 69.2 80.0 79.8 74.3
9 How effective are new, culturally 
appropriate community-level 
interventions (e.g. family therapy) for 
child and adolescent mental disorders 
(including mental retardation and 
epilepsy)?
C/AMD 97.2 77.6 87.0 56.3 79.2 79.7 75.3
10 What is the effectiveness of dispensing 
antipsychotic medication by general 
community health workers, to reduce 
relapse and admission rates in people 
with psychoses?
S/PSYCH 92.9 72.6 80.3 66.7 80.6 79.1 73.9
A/DA, alcohol and drug abuse; C/AMD, child and adolescent mental disorders; CMD, depression and common mental disorders; HPSR, health policy and systems 
research; S/PSYCH, schizophrenia and other psychotic disorders.
a  All the listed research options were scored by technical experts in light of five criteria: (1) their potential to generate new knowledge in an ethical way; (2) the 
likelihood that the intervention resulting from them would be effective; (3) the deliverability, affordability and sustainability of the intervention resulting from them; (4) 
the resulting intervention’s maximum potential for reducing the burden of disease; and (5) their potential effect on equity in the population.
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Table 2. Ten research questions given lowest priority by members of the Lancet Mental Health Group, 2008a
Rank Research question Percentage
Disorder Answer-
able?
Effec-
tive?
Deliver-
able?
Maximum 
impact?
Equi-
table?
Weighted 
score
Agree-
ment
46 How effective are new, antipsychotic drugs 
and delivery methods for improved action and 
fewer side-effects?
S/PSYCH 81.7 70.5 31.7 49.2 53.3 58.0 66.8
47 How effective are new techniques for early 
detection and management of schizophrenia?
S/PSYCH 77.8 52.7 42.5 46.5 63.9 56.5 59.0
48 What new, innovative and appropriate 
interventions can be designed to reduce poor 
mental health outcomes in at-risk children?
C/AMD 64.8 41.3 55.9 46.1 70.8 55.4 55.0
49 What are the benefits of a simpler 
classification of depressive and anxiety 
disorders in practice?
CMD 72.1 52.3 58.3 37.9 55.4 55.0 53.5
50 How effective are new drugs for the preven-
tion and treatment of child and adolescent 
mental disorders such as psychosis?
C/AMD 71.2 43.9 44.8 58.2 56.0 55.0 58.0
51 How can large-scale, efficient and ethically 
sound drug discovery research be carried out 
in LAMI countries?
S/PSYCH 61.9 56.9 44.2 47.5 56.6 54.2 52.9
52 How effective are inexpensive, naturally 
occurring or pharmacological agents that 
make alcohol intake very unpleasant? (E.g. 
some antidepressants are used for smoking 
cessation)
A/DA 78.4 50.0 55.3 27.2 64.9 54.1 59.4
53 What are the benefits of new and innovative 
promotion and prevention programmes?
CMD 60.8 40.0 55.8 50.8 49.2 51.6 54.1
54 How effective are new, innovative interven-
tions for alcohol and drug abuse that target 
biological vulnerability or predisposition, and 
the interplay between genetic and epigenetic 
mechanisms in causation and recovery?
A/DA 62.1 47.1 42.2 49.0 50.9 50.7 52.9
55 What are the benefits of researching 
indigenous or local treatments (including non-
traditional approaches such as acupuncture 
and herbal remedies) as potential treatments?
S/PSYCH 61.9 27.4 51.8 18.4 59.5 42.2 59.6
A/DA, alcohol and drug abuse; C/AMD, child and adolescent mental disorders; CMD, depression and common mental disorders; HPSR, health policy and systems 
research; LAMI, low- and middle-income; S/PSYCH, schizophrenia and other psychotic disorders.
a  All the listed research options were scored by technical experts in light of five criteria: (1) their potential to generate new knowledge in an ethical way; (2) the 
likelihood that the intervention resulting from them would be effective; (3) the deliverability, affordability and sustainability of the intervention resulting from them; (4) 
the resulting intervention’s maximum potential for reducing the burden of disease; and (5) their potential effect on equity in the population.
Priority-setting exercises in the 
mental health field have shown that, 
for schizophrenia, further research is 
needed on its burden to families, the 
cost effectiveness of therapeutic inter-
ventions, ways to bridge the treatment 
gap, and ways to overcome stigmatiza-
tion and social isolation.17 The 2001 
report from the US National Institute 
of Mental Health outlined three prior-
ity areas of research in child and ado-
lescent mental health: developing new 
interventions, moving from efficacy to 
effectiveness in intervention develop-
ment, and moving from effectiveness 
to dissemination in intervention de-
ployment.19 These exercises all resulted 
in broad, general recommendations. 
Although few would disagree with their 
overall messages, they rarely provide 
specific guidance on how to distribute 
resources for health research. In con-
trast, the CHNRI approach generates 
specific outcomes and suggestions, since 
it lists concrete research options and 
assigns them priority scores. The scores 
provide information about the risk as-
sociated with each specific investment 
in health research, under the assump-
tion that reducing the disease burden 
is the main expected end-point. Policy 
makers can then invest in a mixed 
portfolio of health research invest-
ments with a variety of risk levels while 
respecting the values of wider society.
A recent review highlighted the 
scarcity of trials testing interventions for 
the treatment or prevention of mental 
disorders in low- and middle-income 
countries,5 especially in the areas of child 
and adolescent mental disorders and of 
alcohol and substance abuse disorders. 
As an example, the review uncovered 
only 11 trials on alcohol dependence 
or harmful use and only five trials on 
mental retardation. In addition, despite 
the large and increasing burden of 
substance use disorders in developing 
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countries, 34% of all low- and middle-
income countries lack a substance abuse 
policy.27 According to Rajendram et al., 
nearly 58% of all research papers on 
alcohol abuse come from Canada and 
the United States of America, 30% 
from Western Europe, and 10% from 
Australia, Japan, or New Zealand, while 
the rest of the world, which has 87% 
of the disease burden, contributes only 
8%.28 Furthermore, a recent review 
showed that of all psychiatric disorders, 
alcohol and drug abuse had the widest 
treatment gap (78.1%).29
The results of the prioritization ex-
ercise described in this paper, in which 
the top seven research options related 
to alcohol and substance abuse and to 
child and adolescent mental disorders, 
perhaps reflect how these themes have 
been ignored. They provide evidence of 
the need to implement health systems 
research in mental health and carry out 
epidemiological research in low- and 
middle-income countries.
The predominance of research on 
new interventions, particularly against 
drug-related problems, among the low-
priority options is consistent with find-
ings from other exercises based on the 
CHNRI approach.22,23 In these studies, 
research on health policy and systems 
scored highly because of its perceived 
ability to achieve the largest equitable 
gains in reducing disease burden over a 
reasonably short time frame, a criterion 
specified before the scoring was under-
taken. This finding contrasts with trends 
in the allocation of most research fund-
ing and with the United States National 
Institute of Mental Health’s stated main 
priority for research into child and 
adolescent mental health, which is the 
development of new interventions.19 To 
be successful, even new, highly effective 
pharmacological treatments need well-
functioning health systems to deliver 
them and psychosocial interventions to 
accompany them.23
The expert working group listed 
few research questions that addressed 
primary prevention, perhaps due to the 
difficulty of framing research questions 
on prevention in a form that could be 
scored against the five chosen criteria. 
Also, where such questions were listed, 
they were not given high priority, per-
haps because the context within which 
scoring was taking place was initially 
specified as “overall global burden, 
with the improvements expected over 
a time frame of the next 10 years”. 
The CHNRI process highlighted the 
experts’ general lack of optimism that 
preventive interventions could be effec-
tive or make a real difference to mental 
health globally.
It is possible that the experts in 
the working group were systematically 
more biased against preventive invest-
ment options or new interventions than 
against other categories. However, the 
group chosen for this exercise was the 
largest and the most diverse ever to 
conduct a CHNRI exercise to date. It 
is thus unlikely that a different group 
of experts would have arrived at quite 
different results. Nevertheless, the 
CHNRI approach could be subject to 
expert opinion bias because different 
groups may have different opinions. An 
advantage of the CHNRI method over 
previous priority-setting reports14–18 is 
that potential biases are made transpar-
ent in the scoring process. Furthermore, 
the larger and more diverse the group of 
chosen experts, the lower the likelihood 
that scores would significantly devi-
ate from those assigned by a different 
group of experts. Another limitation of 
this study was that the research topics 
were chosen by a self-selected group 
of professionals – albeit a diverse and 
senior one – and that the choice of four 
disorders is not exhaustive, although 
it does represent a significant part of 
the disease burden of mental disorders 
worldwide.
Despite the limitations, this study 
clearly shows a need to invest in research 
on the implementation of existing 
interventions and ways to overcome 
health system constraints in developing 
countries.  ■
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Résumé
Définition des priorités pour la recherche mondiale en santé mentale
Objectif Fixer des priorités en matière d’investissement dans la 
recherche mondiale en santé mentale et proposer un usage plus 
rationnel des fonds dans ce domaine, qui demeure sous-financé 
et sous-étudié.
Méthodes Les Membres du Lancet Mental Health Group ont 
recensé systématiquement et attribué un score aux options 
d’investissement dans des recherches concernant quatre classes 
de troubles : schizophrénie et autres troubles psychotiques 
majeurs, troubles dépressifs majeurs et autres troubles mentaux 
courants, abus d’alcool et autres troubles dus à l’abus de 
substance et troubles de l’enfant et de l’adolescent (classe 
large). En appliquant la démarche de fixation des priorités de la 
Child Health and Nutrition Research Initiative, le Groupe a listé 
diverses questions à étudier et les a évaluées selon des critères 
de résolubilité, d’efficacité, d’aptitude à donner des résultats 
délivrables, d’équité et d’impact sur la charge persistante de 
troubles mentaux. Ces scores ont ensuite été pondérés selon 
le système de valeurs énoncé par un groupe plus important de 
parties concernées.
Résultats Les questions à étudier obtenant le score le plus élevé 
concernaient la recherche sur les politiques et les systèmes de 
santé, les lieux et les modalités de délivrance des interventions 
d’un bon rapport coût/efficacité dans les pays à faibles ressources, 
les recherches épidémiologiques sur la catégorie large des troubles 
de l’enfant et de l’adolescent et les questions relatives à l’abus 
d’alcool et de drogues. Les questions obtenant le score le plus 
bas concernaient le développement de nouvelles interventions, de 
nouveaux médicaments, agents pharmacologiques et vaccins et 
d’autres technologies.
Conclusion Dans le contexte de la santé mentale et à l’horizon des 
dix prochaines années, il serait préférable de combler les lacunes 
les plus criantes en matière de connaissances en investissant 
dans la recherche sur les politiques et les systèmes de santé, 
l’épidémiologie et l’amélioration de la délivrance des interventions 
d’un bon rapport coût/efficacité.
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Resumen
Fijación de prioridades para la investigación mundial en materia de salud mental
Objetivo Establecer las prioridades de inversión en investigaciones 
mundiales sobre salud mental y proponer un uso más racional 
de los fondos en este campo subfinanciado e insuficientemente 
investigado.
Métodos Miembros del Grupo de Salud Mental Lancet procedieron 
a enumerar y puntuar sistemáticamente las opciones de inversión 
en la investigación de cuatro amplias categorías de dolencias: 
esquizofrenia y otros trastornos psicóticos graves, depresión 
mayor y otros trastornos mentales comunes, abuso de alcohol 
y otros trastornos por abuso de sustancias, y la gran variedad 
de trastornos mentales en niños y adolescentes. Aplicando el 
criterio de fijación de prioridades de la Iniciativa de Salud del 
Niño e Investigación Nutricional, el grupo confeccionó una lista 
de diversos temas de investigación y los evaluó conforme a los 
criterios de justificación, eficacia, viabilidad, equidad e impacto 
potencial en la carga persistente de trastornos de salud mental. Las 
puntuaciones se ponderaron luego de acuerdo con el sistema de 
valores expresado por un grupo más amplio de interesados directos.
Resultados Los temas de investigación que obtuvieron una mayor 
puntuación guardan relación con la investigación de políticas y 
sistemas de salud, la determinación de dónde y cómo aplicar 
intervenciones costoeficaces ya existentes en un contexto de 
pocos recursos, y la investigación epidemiológica relacionada 
con las categorías generales de trastornos mentales de niños 
y adolescentes o con aspectos del abuso de alcohol y drogas. 
Los temas con menor puntuación fueron los relacionados con el 
desarrollo de nuevas intervenciones y nuevos medicamentos o 
agentes farmacológicos, vacunas y otras tecnologías.
Conclusión En el contexto de la salud mental mundial y dentro 
del horizonte de los próximos 10 años, lo más conveniente 
sería llenar algunos vacíos de vital importancia en los actuales 
conocimientos invirtiendo en la investigación de las políticas y los 
sistemas de salud, la epidemiología y la mejora de la aplicación 
de intervenciones costoeficaces.
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صخلم
ةيسفنلا ةحصلا في ةيلماعلا ثوحبلل تايولولأا عضو
 ،ةيسفنلا  ةحصلا  في  ةيلماعلا  ثوحبلا  في  رماثتسلاا  تايولوأ  عضو  :فدهلا
 ةحيحشلا تلااجلما هذه في لاوملأا نم ديشرلا مادختسلاا نم ديزلما حاترقاو
.اهلوح تاساردلا لقت يتلاو دراولما
 ،يجهنم  لكشبو  ،ةيسفنلا  ةحصلل  تسنلا  ةعومجم  ءاضعأ  دعأ  :ةقيرطلا
 فانصأ ةعبرأ في ثوحبلا في رماثتسلاا تارايخل )مييقت تاجرد( زارحأو مئاوق
 ىبركلا ةيناه ُّذلا تابارطضلااو ماصُفلا يهو تابارطضلاا نم فيطلا ةضيرع
 ،ىرخلأا ةعئاشلا ةيسفنلا تابارطضلااو يربكلا بيائتكلاا بارطضلااو ،ىرخلأا
 عساولا فنصلاو ،نامدلإل ةببسلما داولما يطاعت تابارطضاو لوحكلا ةرقاعمو
 تدعأ  دقو  .ينقهارلماو  لافطلأا  ىدل  ةيسفنلا  تابارطضلاا  نم  فيطلا
 يرياعم مادختساب اهيمدقت عم ةفلتخم ثوحبب قلعتت ةلئسلأا مئاوق ةعومجلما
 رثلأاو  ،فاصنلإاو  ،ليصوتلا  لىع  ةردقلاو  ،ةيلاعفلاو  ،ةباجلإا  لىع  ةردقلا
 تدعأ  دقو  ،ةيسفنلا  ةحصلا  في  تابارطضلاا  ءبع  رارمتسا  لىع  لمتحلما
 لوح  ثوحبلا  ةردابلم  تايولولأا  عضو  بولسأ  مادختساب  كلذ  ةعومجلما
 اهنع برعي ميق ماظنل ًاقفو زارحلأا تنزو دقو .لافطلأا ىدل ةحصلاو ةيذغتلا
.ةينعلما فارطلأا نم بركأ ةعومجم
 تاجرد( زارحلأا عفرأ لىع تزاح يتلا ثوحبلا اياضق تناك دقل :تادوجولما
 ميدقت نكيم فيكو نيأ ،ةيحصلا تاسايسلاو مُظُنلا ثوحبب قلعتت )مييقتلا
 ةليلقلا  تائيبلا  في  فيلاكتلا  ءاقل  ةيلاعفلا  ةيلاعلا  ةدوجولما  تلاخدتلا
 يتلا  لاجلما  ةضيرعلا  تائفلا  لوح  ةيئابولا  ثوحبلا  بناج  لىإ  ،دراولما
 اياضقب  ةقلعتلما  كلت  وأ  ينقهارلماو  لافطلأل  ةيسفنلا  تابارطضلااب  قلعتت
 زارحلأا  ضفخأ  لىع تزاح يتلا  اياضقلا  امأ  تاردخلماو  تايلوحكلا  ةرقاعم
 وأ تاحاقل وأ ةينلاديص لماوع وأ ةديدج ةيودأ وأ تلاخدت ريوطتب قلعتتف
.ةديدج ىرخأ تايجولونكت
 تاونسلل ينمزلا راطلإا نمضو ةيسفنلا ةحصلل يلماعلا قايسلا في :جاتنتسلاا
 نم فراعلما في ةمساحلا تاوجفلا ءلم لضفلأا نم نوكيس ةمداقلا ةشرعلا
 لىإ تايئابولاو ةيحصلا تاسايسلاو مُظُنلا  لوح ثوحبلا في رماثتسلاا للاخ
..فيلاكتلا ءاقل ةيلاع ةيلاعفب مستت يتلا تلاخدتلا ءاتيإ ينسحت بناج
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